Tenet director plans sale of 10,000 shares
A Rule 144 notice registers director Richard J. Mark’s intent to sell up to 10,000 THC common shares tied to vested equity awards.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
TENET HEALTHCARE CORP (THC) has a notice of proposed sale under Rule 144 filed on behalf of director Richard J. Mark. The filing covers the potential sale of 10,000 shares of common stock through Fidelity Brokerage Services LLC on the NYSE. Listed share amounts arise from multiple restricted stock vesting compensation awards scheduled between May 2024 and May 2026.
Key Figures
Key Terms
Rule 144 regulatory
Restricted Stock Vesting financial
attorney-in-fact regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Who is the insider involved in the TENET HEALTHCARE CORP (THC) Form 144?
What types of equity awards are tied to the THC Form 144 filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.